<DOC>
	<DOCNO>NCT01477528</DOCNO>
	<brief_summary>The purpose observational study obtain multi-center data HeartMate II ( HMII ) patient manage reduced anticoagulation anti-platelet regime , incidence thrombotic bleeding adverse event associate regime .</brief_summary>
	<brief_title>Study Reduced Anti-coagulation/Anti-platelet Therapy Patients With HeartMate II Left Ventricular Assist System ( LVAS ) ( TRACE )</brief_title>
	<detailed_description />
	<criteria>HeartMate II Left Ventricular Assist Device ( LVAD ) patient Patient sign informed consent data collection . Patient discharge , discharge , hospital initial LVAD implant surgery . Patient : time enrol study , currently , intention maintain reduce antithrombotic therapy ( RT ) chronic longterm management . OR On January 1 , 2011 patient maintain , initiated intention maintain , reduce antithrombotic therapy ( RT ) chronic longterm management ; RT subsequently discontinue due adverse event transplant , explant , death . Patients acute management antithrombotic agent final decision long term antithrombotic strategy . Patients require legal representative sign consent form , rather . Patient manage antithrombotic agent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>HeartMate II</keyword>
	<keyword>Anticoagulation</keyword>
	<keyword>Thoratec Corporation</keyword>
</DOC>